Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Denali Therapeutics Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Denali Therapeutics Inc. since year 2005.
Table 2 shows the detailed insider transactions of Denali Therapeutics Inc. since 2005.
The reporting company's ticker symbol is DNLI. The reporting company's CIK number is 1714899.
The total value of stock buying since 2005 is $4,950,000.
The total value of stock sales since 2005 is $3,581,933.
The total value of stock option exercises since 2005 is $83,646.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-12||Schuth Alexander O. (COO and Secretary)||Sale||2,500||20.80||52,000|
|2018-12-11||Schuth Alexander O. (COO and Secretary)||Sale||2,500||20.22||50,550|
|2018-12-10||Schuth Alexander O. (COO and Secretary)||Sale||2,500||20.18||50,450|
|2018-12-03||Ho Carole (Chief Medical Officer)||Sale||17,500||18.80||328,930|
|2018-12-03||Watts Ryan J. (President and CEO)||Sale||18,333||18.79||344,458|
|2018-11-15||Ho Carole (Chief Medical Officer)||Sale||17,500||18.07||316,155|
|2018-11-15||Watts Ryan J. (President and CEO)||Sale||13,588||18.12||246,241|
|2018-11-13||Watts Ryan J. (President and CEO)||Sale||4,746||18.00||85,428|
|2018-10-02||Schuth Alexander O. (COO and Secretary)||Option Ex||7,043||7.44||52,399|
|2018-10-01||Ho Carole (Chief Medical Officer)||Sale||17,500||21.72||380,100|
|2018-10-01||Watts Ryan J. (President and CEO)||Sale||18,333||21.72||398,192|
|2018-09-04||Ho Carole (Chief Medical Officer)||Sale||17,500||19.05||333,375|
|2018-09-04||Watts Ryan J. (President and CEO)||Sale||18,333||19.06||349,426|
|2018-08-29||Ho Carole (Chief Medical Officer)||Sale||17,500||18.04||315,700|
|2018-08-29||Watts Ryan J. (President and CEO)||Sale||18,334||18.05||330,928|
|2018-06-22||Schuth Alexander O. (COO and Secretary)||Option Ex||5,918||5.28||31,247|
|2017-12-12||Crestline Management, Lp (10% Owner)||Buy||275,000||18.00||4,950,000|
Insider trading activities including stock purchases, stock sales, and option exercises of DNLI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Denali Therapeutics Inc. (symbol DNLI, CIK number 1714899) see the Securities and Exchange Commission (SEC) website.